09/21/10 | BARDA Funds Medical Countermeasure Innovation |
Eight contracts for products and technology to protect Americans awarded for $55-$100 million | |
09/20/10 | Dow AgroSciences, Wageningen UR Enter into Agreement to Use EXZACTTM Precision Technology |
Research Will Focus on Improving Potato Through Precise Genome Modification | |
09/16/10 | Clean Energy Trust Receives $1.05 Million U.S. Department of Energy Grant; Organization Looks to Create Clean Energy Ecosystem in Illinois and Midwest |
Pritzker, Crown, Polsky Among Organization Founders | |
09/16/10 | Cellular Dynamics International, ACEA Biosciences, and Roche Applied Sciences Cooperate to Evaluate iCell Cardiomyocytes on the xCELLigence System |
The partnership combines CDI’s induced pluripotent stem cell (iPSC)-derived heart cells, iCell Cardiomyocytes, with the xCELLigence RTCA System. The xCELLigence System is developed by ACEA and Roche Applied Science and marketed by Roche. | |
09/16/10 | Oslo Cancer Cluster and Shanghai Institute of Materia Medica Sign Groundbreaking MoU to Form Third Pillar of Global Biosciences Gateway |
Overall the collaboration between OCC and SIMM will help create an infrastructure in Shanghai and Oslo for efficient drug discovery combined with high quality oncology clinical trials, and access to both European and Chinese regulatory and safety experts. | |
09/14/10 | Oxford Nanopore strengthens collaboration with University of Oxford |
The Company will fund research in the laboratories of Professor Hagan Bayley, University of Oxford, and will partner exclusively with the University to develop revolutionary products for molecular analysis from these new discoveries. | |
09/14/10 | Intel Capital Invests $30 Million in Four U.S. Technology Companies |
The deals include Moab® unified automation intelligence technology provider Adaptive Computing; analog IC physical design software developer Ciranova; cloud computing infrastructure and services provider Joyent; and energy software and services provider Nexant. | |
09/13/10 | AB SCIEX and the University of Melbourne Partner to Develop Breakthrough Approach to Drug Metabolism Studies of Biopharmaceuticals |
Joint Project to Help Advance Protein-Based Drugs Through Regulatory Processes | |
08/26/10 | Construction Begins Today on EVSO’s Solar Demonstration Project at TSU |
Installation to give students hands-on experience with solar technology | |
08/26/10 | Solazyme Adds Bunge as Strategic Investor in Series D |
Solazyme, Inc. is a renewable oil and bioproducts company and the leader in algal biotechnology. | |
[ <- 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 -> ] |